期刊文献+

白血病细胞纤溶活性及机制的研究 被引量:1

Fibrinolytic activity and its mechanisms in various leukemic cell lines
暂未订购
导出
摘要 目的:研究白血病细胞纤溶活性及其与尿激酶受体(uPAR)和膜联蛋白Ⅱ(annexinⅡ)表达的关系。方法:用发色底物法测定NB4、SHI-1、K562、Jurkat、Raji细胞与纤溶酶原相互作用后白血病细胞的纤溶活性。用流式细胞术检测NB4、SHI-1、K562、Jurkat、Raji细胞表面uPAR和annexinⅡ的表达。以RT-PCR方法检测uPAR基因和annexinⅡ基因在NB4、SHI-1、K562、Jurkat、Raji细胞系中的表达。结果:SHI-1细胞和NB4细胞的纤溶活性明显高于Raji、K562和Jurkat细胞的纤溶活性。uPAR和annexinⅡ在NB4细胞的表达率分别为(13.15±1.61)%与(95.97±1.19)%,在SHI-1细胞的表达分别为(99.00±0.26)%与(90.35±2.15)%,在K562、Jurkat、Raji细胞的表达均低。NB4细胞annexinⅡ的基因表达较SHI-1细胞高,K562和Jurkat细胞中未检测到annexinⅡ的基因表达。NB4和SHI-1细胞uPAR基因表达高于Jurkat和K562细胞,Raji细胞中未检测到uPAR基因的表达。结论:NB4与SHI-1白血病细胞株存在高纤溶活性,与annexinⅡ和uPAR的表达增高相关,这可能是早幼粒细胞白血病与急性单核细胞白血病患者在临床上易发生出血及并发弥散性血管内凝血的一个重要原因。 AIM: To study the relation between expression of uPAR and annexin Ⅱ and fibrinolytic activity in various leukemic cell lines. METHODS: The plasma activity was measured under the reaction between cells of NB4, SHI - 1, K562, Jurkat, Raji and plaminogen by chromogenic assay. The protein expressions of uPAR and annexin Ⅱ in cells of NB4, SHI - 1, K562, Jurkat, Raji were detected by flow cytometry method. The mRNA expressions of uPAR and annexin Ⅱ in cells of NB4, SHI -1, K562, Jurkat, Raji were detected by RT - PCR. RESULTS : The plasma activity in SHI - 1 cells and NB4 cells were higher obviously than that in Raji, K562 and Jurkat cells. The protein expression ratio of uPAR and annexin Ⅱ in NB4 cells were ( 13. 15 ± 1.61 )% and (95.97 ± 1.19)% , respectively, they were (99. 00 ± 0. 26)% , (90. 35 ±2. 15)% respectively in SHI - 1 cells, and they were lower in K562, Jurkat, Raji cells. The expression of annexin Ⅱ mRNA in NB4 cells was higher than that in SHI - 1 cells, and they were undectectable in K562 and Jurkat cells. The expression of uPAR mRNA in NB4 and SHI - 1 cells were higher than that in Jurkat and K562 cells. The expression of uPAR mRNA in Raji cells was undectectable. CONCLUSION: The primary hyperfibrinolysis in leucocylhemia cells was observed, and relation was closely with the expression of annexinⅡ. It might be the main reason for bleeding and disseminated intravasculax coagulation in patients with acute promyelocytic leukemia and acute monocytic leukemia.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2007年第2期250-253,共4页 Chinese Journal of Pathophysiology
基金 江苏省卫生厅科技基金会重点科研课题资助项目(No.k200401)
关键词 白血病 早幼粒细胞 急性 受体 尿激酶 基因表达 Leukemia, promyelocytic, acute Receptors, urokinase Gene expression
  • 相关文献

参考文献12

  • 1Falanga A,Rickles FR.Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukemia[J].Best Pract Res Clin Haematol,2003,16(3):463-482.
  • 2吴方,徐志红,杜萱,璩斌,王学锋,王鸿利.急性白血病并发出血患者的止凝血特点及其与预后的关系[J].临床血液学杂志,2003,16(4):156-159. 被引量:5
  • 3张宏,梁建英,李军,傅晋翔.急性早幼粒细胞白血病患者凝血纤溶指标的检测与分析[J].苏州大学学报(医学版),2004,24(4):521-522. 被引量:8
  • 4Aref S,El-Sherbiny M,Mabed M,et al.Urokinase plasminogen activator receptor and soluble matrix metalloproteinase -9 in acute myeloid leukemia patients:a possible relation to disease invasion[J].Hematology,2003,8(6):385 -391.
  • 5Hajjar KA,Jacovina AT,Chaeko J.An endothelial cell receptor for plasminogen/tissue plasminogen activator,Ⅰ:identify with annexin Ⅱ[J].J Biol Chem,1994,269(33):21191 -21197.
  • 6Ling Q,Andrew TJ,Amnkumar D,et al.Annexin Ⅱ regulates fibrin homeostasis and neoangiogenesis in vivo[J].J Clin Invest,2004,113(1):38 -48.
  • 7Olwill SA,Gilmore WS,McGlynn H,et al.The cell surface expression of annexin Ⅱ on various myeloid leukemic cell lines[J].Br J Haematol,2002,117(suppl):22.
  • 8Menell JS,Cesarman GM,Jacovina AT,et al.Annexin Ⅱ and bleeding in acute promyelocytic leukemia[J].N Engl J Med,1999,340(13):994-1004.
  • 9Zhang XH,Zhou HR,Wang J,et al.Arsenic trioxide,retinoic acid and Ara-c regulated the expression of annexin Ⅱ on the surface of APL cells,a novel co receptor for plasminogen/tissue plasminogen activator[J].Thromb Res,2002,106(1):63 -70.
  • 10Shane A,Hugh M,William S,et al.Annexin Ⅱ cell surface and mRNA expression in human acute myeloid leukemia cell lines[J].Thromb Res,2005,115 (1):109 -114.

二级参考文献13

  • 1中华医学会血液分会血栓与止血组.弥散性血管内凝血前期(pre—DIC)诊断标准[J].中国实验诊断学,2000,2:93-96.
  • 2Cho Jnowski K, Trelinski J, Wawrzyniak E, et al. The influence of low molecular weight heparin on the intravascular activation of the coagulation system in patients with acute leukemia during induction chemotherapy-report of a prospective randomized study. Leuk Lymphoma, 2002,43:1021-1028.
  • 3Wada H, Gabazza E, Nakaski. Diagnosis of disseminated intravascular coagulation by hemastatic molecular markers. Semin Thromb Hemost, 2000,26 : 17- 21.
  • 4Asakura H, Ontachi Y, Mizutani T, et al. Elevated levels of free tissue factor pathway inhibitor antigen in case of disseminated intravascular coagulation caused by various underlying diseases. Blood Coagul Fibrinolysis,2001,12:1-81.
  • 5Okugawa Y, Wada H, Noda T, et al. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation. Am J Haematol, 2000,65 : 557- 563.
  • 6Lanza F, Castoldi G L, Castagnari B, et al. Expression and functional role of u-PAR in normal and acute leukemia cells. British Journal of Haematology, 1998, 103:110-123.
  • 7Shinji N, Ken-ichi I, Minoru F, et al. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal banters . Int J Cancer, 1999, 79:179-186 .
  • 8Tallman MS,Kwaan HC.Reassesing the hemostatic disorder associated with acute promyelocytic leukemia[J].Blood,1992,79:543-533.
  • 9De Stefanov,Teofilil,Sicas,et al. Effect of all_trans retinoic aci on procoagulant and fibrinolytic activities of cultured blast cell from patients with acute promyelocytic leukemia[J].Blood,1992,79:3535-3541.
  • 10Falanga A,Iacoviello L,Evangelista V,et al. Loss of cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans retinoic acid[J].Blood,1995,86:1072-1081.

共引文献10

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部